News | Breast Imaging | July 12, 2022

The Strathroy Middlesex General Hospital (SMGH) has adopted Molli — a precise, easy-to-use new technology for breast cancer localization. 

medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform

July 12, 2022 — The Strathroy Middlesex General Hospital (SMGH) has adopted Molli — a precise, easy-to-use new technology for breast cancer localization. Recently, an SMGH team participated in its first breast-conserving surgical procedure using Molli. SMGH is the first hospital in the southwest Ontario region to use this technology. 

Molli Surgical’s Health Canada-approved and FDA-cleared Molli features the Molli Marker — the smallest localization marker on the market — and is designed to give a better patient experience over traditional wire localization. The Molli Wand detects the marker and visualizes its location on a tablet, helping surgeons locate lesions more efficiently with improved accuracy. Molli is also a great benefit for patients as it allows for more convenient scheduling of marker placement. 

“Molli is an innovative and revolutionary way of localizing breast masses that cannot be felt. It allows for a less painful and more effective way of finding the breast disease that needs to be removed, during surgery,” says Dr. Vipan Jain, MHA General Surgeon. “The marker can be inserted weeks before the surgical date, allowing for easier scheduling for patients and no loss of signal during surgery, making it a better option than the radioactive seed guide. Once placed, the chances of it moving and/or dislodging are virtually nonexistent, making it a better option than the conventional wire guide. We're seeing these benefits, and with the ease of use in the operating room, I believe Molli is a better option for patients.” 

“Congratulations to the team at SMGH and Molli Surgical for bringing this innovative, precision technology to our community — and for the difference it will make for Strathroy patients and for their families,” said Joanne Vanderheyden, Mayor of Strathroy-Caradoc

“We’re very pleased to do our part to help improve the patient experience with the use of Molli at Strathroy Middlesex General Hospital,” said Fazila Seker, President and CEO of Molli Surgical. “We believe that by improving the way we care for people who are experiencing breast surgery — together with creating more efficiency in radiology and surgery departments — creates a better overall experience for both physicians and their patients, and ultimately strengthens hospitals and the communities they serve.” 

For more information: http://mollisurgical.com/ 


Related Content

News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
Subscribe Now